The change affects women with atypical genetics who have been able to compete if they suppressed their testosterone levels.
This marks Marius Pharmaceuticals’ fifth U.S. patent, further reinforcing its leadership in the field of testosterone replacement therapy. The newly allowed patent specifically covers the company’s ...
Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8536 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback